Incyte

Glowing puzzle piece fitting into puzzle

Biotech

Incyte inks $2B deal to add Star biz to late-phase constellation

The takeover covers a late-phase bleeding disorder drug candidate that could support Incyte’s ambition to grow through the loss of Jakafi patents.

Nick Paul Taylor Jun 8, 2026 9:07am

lab artificial intelligence

Incyte pays Genesis $80M to expand AI-fueled drug discovery pact

May 20, 2026 10:22am

Artificial intelligence

Incyte inks deal with Edison to train AI through drug discovery

May 19, 2026 10:30am

photo of a pair of hands that show the skin condition vitiligo

Incyte’s vitiligo bet scores ph. 3 wins but can’t shake off Rinvoq

Apr 28, 2026 9:52am

Parachute over ocean

Tang takes over Aurinia after FDA brouhaha—Chutes & Ladders

Mar 27, 2026 11:05am

Lifeline

Midsize biotechs form coalition to fight against MFN policy

Feb 25, 2026 1:05pm